New hormone drug to cheer flagging libido
A new hormone replacement therapy being developed by a British company could be the answer to flagging libido in middle-aged men, it was claimed yesterday, writes Magnus Grimond.
Hormone replacement has become an established treatment for post-menopausal women to combat osteoporosis, or "brittle bone disease". But recent research has focused on the use of similar treatments for men suffering from the so-called "male menopause" - decreased libido, impotence, tiredness and depression.
Yesterday, the development of an oral form of the male hormone testosterone took a major step forward when Cortecs International, one of a growing band of UK companies set up to exploit medical breakthroughs, signed a collaboration agreement with a Danish group to finance development of the drug.
But sufferers may have to wait a while yet for relief. Cortecs does not expect to receive regulatory approval until the year 2000, with a further 18 months to two years before it hits the market.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies